Clinical relevance of high sensitivity C-reactive protein in cardiology
Dalia Adukauskienė1, Aušra Čiginskienė1, Agnė Adukauskaitė2
1Department of Intensive Care, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Insights
High-sensitivity C-reactive protein (hsCRP) is crucial for understanding cardiovascular diseases (CVD). Guidelines now recommend hsCRP testing for both primary and secondary CVD prevention strategies.
Area of Science:
- Cardiology
- Clinical Chemistry
- Inflammation Research
Background:
- Cardiovascular diseases (CVD) are a leading global cause of mortality.
- High-sensitivity C-reactive protein (hsCRP) is investigated for its role in CVD pathogenesis, prognosis, and prevention.
- The inflammatory origin of atherosclerosis is increasingly debated, questioning whether elevated hsCRP is a cause or consequence.
Purpose of the Study:
- To review the current understanding and clinical application of hsCRP testing in cardiovascular diseases.
- To summarize controversial data and guideline recommendations regarding hsCRP in CVD management.
- To explore the role of hsCRP in various cardiovascular conditions and the development of CRP-modulating medications.
Main Methods:
- Review and synthesis of controversial data from multiple studies.
- Analysis of current clinical guidelines recommending hsCRP testing.
- Examination of hsCRP's role in diverse cardiovascular pathologies and treatment efficacy.
Main Results:
- Guidelines recommend hsCRP testing for primary CVD prevention, including risk stratification and statin therapy selection.
- hsCRP testing is advised for secondary CVD prevention, aiding prognosis and evaluating treatment efficacy.
- hsCRP plays a role in heart failure, atrial fibrillation, hypertension, valve pathology, and stent-related complications.
Conclusions:
- hsCRP testing is a valuable tool in both primary and secondary prevention of cardiovascular diseases.
- Understanding hsCRP's role aids in risk stratification, treatment selection, and prognosis across various cardiovascular conditions.
- Ongoing research investigates medications that target hsCRP concentration for potential therapeutic benefits.
Abstract:
Coping with cardiovascular diseases (CVD), which are of the main causes of death worldwide, has influenced investigation of high sensitivity CRP (hsCRP) and its role in pathogenesis, prognosis and prevention of CVD. hsCRP can be synthesized in vascular endothelium, atherosclerotic plaques, and theory of inflammatory origin of atherosclerosis is being more widely debated, raising questions, whether higher hsCRP plasma concentration might be the cause or the consequence. Summing up controversial data from multiple studies, guidelines recommend hsCRP testing for both, primary (stratifying CVD risk groups, selecting patients for statin therapy) and secondary CVD prevention (prognosis of CVD and its treatment complications, evaluation of treatment efficacy in moderate CVD risk group). hsCRP testing also has role in heart failure, atrial fibrillation, arterial hypertension, valve pathology and prognosis of coronary stent thrombosis or restenosis. Medications (the well-known and the new specific - CRP binding) affecting its concentration are being investigated as well.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
